Skip to main content
. 2016 Jun 29;146(9):1769–1774. doi: 10.3945/jn.116.233239

FIGURE 2.

FIGURE 2

Plasma iron and inflammatory markers at day 0, day 28, and day 56 in 100 Ugandan children aged 6–59 mo with malaria and anemia who started iron therapy concurrently with antimalarial treatment (immediate, I) or 28 d after antimalarial treatment (delayed, D). Error bars reflect SD for arithmetic mean and 95% CI for geometric means. Sample size for indicators (day 0, day 28, day 56) were as follows: hemoglobin (I group: 50, 43, 42; D group: 49, 41, 42), zinc protoporphyrin (I group: 50, 46, 45; D group: 49, 43, 42), plasma ferritin (I group: 50, 45, 43; D group: 48, 40, 43), plasma sTfR (I group: 50, 45, 43; D group: 48, 41, 43), plasma hepcidin (I group: 48, 45, 42; D group: 47, 39, 43), and plasma CRP (I group: 48, 45, 43; D group: 47, 41, 41). CRP, C-reactive protein; sTfR, soluble transferrin receptor.